280 related articles for article (PubMed ID: 27002311)
1. HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction.
Walton DC; Hiho SJ; Cantwell LS; Diviney MB; Wright ST; Snell GI; Paraskeva MA; Westall GP
Am J Transplant; 2016 Sep; 16(9):2695-703. PubMed ID: 27002311
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study.
Sapir-Pichhadze R; Tinckam K; Quach K; Logan AG; Laupacis A; John R; Beyene J; Kim SJ
Am J Transplant; 2015 Jan; 15(1):137-48. PubMed ID: 25521856
[TBL] [Abstract][Full Text] [Related]
3. Eplet Mismatch Load and
Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
[TBL] [Abstract][Full Text] [Related]
4. Comparison of human leukocyte antigen immunologic risk stratification methods in lung transplantation.
Hiho SJ; Levvey BJ; Diviney MB; Snell GI; Sullivan LC; Westall GP
Am J Transplant; 2024 May; 24(5):827-838. PubMed ID: 37981213
[TBL] [Abstract][Full Text] [Related]
5. HLA class II Eplet mismatch predicts De Novo DSA formation post lung transplant.
Walton DC; Cantwell L; Hiho S; Ta J; Wright S; Sullivan LC; Snell GI; Westall GP
Transpl Immunol; 2018 Dec; 51():73-75. PubMed ID: 30321645
[TBL] [Abstract][Full Text] [Related]
6. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
Bryan CF; Chadha V; Warady BA
Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
[TBL] [Abstract][Full Text] [Related]
7. Specific human leucocyte antigen-DQ risk epitope mismatches are associated with chronic lung allograft dysfunction after lung transplantation.
Ennis SL; Olsen N; Tong WWY; Goddard L; Watson N; Weston L; Iqbal A; Patel P; Malouf MA; Plit ML; Darley DR
Am J Transplant; 2023 Jul; 23(7):1009-1021. PubMed ID: 37054889
[TBL] [Abstract][Full Text] [Related]
8. Development of bronchiolitis obliterans syndrome despite blood chimerism in human lung transplant recipients.
Calhoun R; SivaSai KS; Sundaresan S; Trulock EP; Lynch JP; Patterson GA; Cooper JD; Mohanakumar T
Transpl Int; 1999; 12(6):439-46. PubMed ID: 10654356
[TBL] [Abstract][Full Text] [Related]
9. Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation.
Yanyiam P; Kantachuvesiri S; Thammanichanond D
Transplant Proc; 2024 Apr; 56(3):515-520. PubMed ID: 38368130
[TBL] [Abstract][Full Text] [Related]
10. Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss.
Sapir-Pichhadze R; Zhang X; Ferradji A; Madbouly A; Tinckam KJ; Gebel HM; Blum D; Marrari M; Kim SJ; Fingerson S; Bashyal P; Cardinal H; Foster BJ
Kidney Int; 2020 Apr; 97(4):778-785. PubMed ID: 32059998
[TBL] [Abstract][Full Text] [Related]
11. Identification of risk epitope mismatches associated with de novo donor-specific HLA antibody development in cardiothoracic transplantation.
McCaughan JA; Battle RK; Singh SKS; Tikkanen JM; Moayedi Y; Ross HJ; Singer LG; Keshavjee S; Tinckam KJ
Am J Transplant; 2018 Dec; 18(12):2924-2933. PubMed ID: 29847022
[TBL] [Abstract][Full Text] [Related]
12. Matchmaker, matchmaker make me a match: Opportunities and challenges in optimizing compatibility of HLA eplets in transplantation.
Lemieux W; Mohammadhassanzadeh H; Klement W; Daniel C; Sapir-Pichhadze R
Int J Immunogenet; 2021 Apr; 48(2):135-144. PubMed ID: 33426788
[TBL] [Abstract][Full Text] [Related]
13. The impact of HLA-DR mismatch status on retransplant-free survival and bronchiolitis obliterans syndrome‒free survival among sensitized lung transplant recipients.
Courtwright AM; Kamoun M; Kearns J; Diamond JM; Golberg HJ
J Heart Lung Transplant; 2020 Dec; 39(12):1455-1462. PubMed ID: 33071182
[TBL] [Abstract][Full Text] [Related]
14. Alloantibody Responses After Renal Transplant Failure Can Be Better Predicted by Donor-Recipient HLA Amino Acid Sequence and Physicochemical Disparities Than Conventional HLA Matching.
Kosmoliaptsis V; Mallon DH; Chen Y; Bolton EM; Bradley JA; Taylor CJ
Am J Transplant; 2016 Jul; 16(7):2139-47. PubMed ID: 26755448
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
[TBL] [Abstract][Full Text] [Related]
16. Degree of HLA class II eplet mismatch load improves prediction of antibody-mediated rejection in living donor kidney transplantation.
Tafulo S; Malheiro J; Santos S; Dias L; Almeida M; Martins S; Pedroso S; Mendes C; Lobato L; Castro-Henriques A
Hum Immunol; 2019 Dec; 80(12):966-975. PubMed ID: 31604581
[TBL] [Abstract][Full Text] [Related]
17. Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients.
Kishikawa H; Kinoshita T; Hashimoto M; Fukae S; Taniguchi A; Yamanaka K; Nakagawa M; Nishimura K
Transplant Proc; 2018 Oct; 50(8):2388-2391. PubMed ID: 30316363
[TBL] [Abstract][Full Text] [Related]
18. DQA1 Eplet Mismatch Load As an Independent Risk Factor of CLAD After Lung Transplantation.
González-López E; Mora-Cuesta VM; Roa-Bautista A; Comins-Boo A; Renaldo A; Irure-Ventura J; Iturbe-Fernández D; Tello-Mena S; San Segundo D; Cifrián-Martínez J; López-Hoyos M
Transplant Direct; 2023 Jul; 9(7):e1513. PubMed ID: 37389015
[TBL] [Abstract][Full Text] [Related]
19. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
[TBL] [Abstract][Full Text] [Related]
20. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.
Duquesnoy RJ; Awadalla Y; Lomago J; Jelinek L; Howe J; Zern D; Hunter B; Martell J; Girnita A; Zeevi A
Transpl Immunol; 2008 Feb; 18(4):352-60. PubMed ID: 18158123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
